Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Andrea Németh has successfully applied to the John Fell Fund to establish the Oxford Neurodevelopment Consortium (OxNDC).

Neurodevelopmental disorders include intellectual disability, autism, cerebellar ataxias, epilepsies, and many others. Mental health and neurodegenerative disorders may also have developmental antecedents. They are lifelong conditions with few disease-modifying treatments.  

Large-­scale DNA sequencing studies are unravelling the genetic basis of some of these conditions and this is providing exciting new opportunities to study these conditions, especially when combined with other clinical and basic sciences.

The aim of the OxNDC is to bring together all interested clinical and basic scientists working on neurodevelopmental disorders in Oxford. This will include those working in imaging and neuropathology, and those using cellular or animal models as well those using patient cohorts for genetic or other analysis.

The consortium will strengthen existing collaborations; form new collaborations; and share ideas, resources, materials and protocols. It will create a critical mass of clinicians and scientists with a new momentum capable of securing competitive funding, breaking new ground, and identifying potential therapeutic targets.

Get involved

The inaugural meeting of the OxNDC is planned for March. Those interested, including anyone who would like to present their work, can contact andrea.nemeth@ndcn.ox.ac.uk for more information.

Similar stories

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.

Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd

Mapping brain network activity from structural connectivity using deep learning

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

How our dreams changed during the COVID-19 pandemic

This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

Blood lipoprotein levels linked to future risk of amyotrophic lateral sclerosis

Greater understanding of the role of lipoproteins could support screening and efforts to develop treatments.